Research / CBT / Fundamental state Inspectable configuration
State dimensions Filing 0000950170-23-065844 General Corporate
Debt relative to revenue 10th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.debt_to_revenue
27.52% · OPTIONAL · VALID
Capex intensity 55th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
6.21% · OPTIONAL · VALID
Operating cash generation 85th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
15.14% · OPTIONAL · VALID
Revenue growth 25th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
-9.03% · CORE · VALID
Inventory pressure 10th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
14.88% · OPTIONAL · VALID
Gross margin 65th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
21.34% · CORE · VALID
Operating margin 70th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
13.38% · CORE · VALID
R&D intensity 30th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
1.45% · OPTIONAL · VALID
SBC intensity 45th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.51% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 36 states Self-history eligible
Sep 30, 2021 9/9 normalized Level 3 Dec 31, 2021 9/9 normalized Level 3 Mar 31, 2022 9/9 normalized Level 3 Jun 30, 2022 9/9 normalized Level 3 Sep 30, 2022 9/9 normalized Level 3 Dec 31, 2022 9/9 normalized Level 3 Mar 31, 2023 9/9 normalized Level 3 Jun 30, 2023 9/9 normalized Level 3 Sep 30, 2023 9/9 normalized Level 3 Dec 31, 2023 9/9 normalized Level 3 Mar 31, 2024 9/9 normalized Level 3 Jun 30, 2024 9/9 normalized Level 3 Sep 30, 2024 9/9 normalized Level 3 Dec 31, 2024 9/9 normalized Level 3 Mar 31, 2025 9/9 normalized Level 3 Jun 30, 2025 9/9 normalized Level 3 Sep 30, 2025 9/9 normalized Level 3 Dec 31, 2025 9/9 normalized Level 3 Mar 31, 2026 9/9 normalized Level 3 Jun 30, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 127.69%
Current 27.52%
Delta -100.16% Capex Intensity Decreased
Previous 8.26%
Current 6.21%
Delta -2.06% Cash Generation Decreased
Previous 25.10%
Current 15.14%
Delta -9.97% Growth Increased
Previous -15.75%
Current -9.03%
Delta 6.73% Inventory Pressure Decreased
Previous 61.16%
Current 14.88%
Delta -46.28% Margin Decreased
Previous 23.04%
Current 21.34%
Delta -1.69% Profitability Decreased
Previous 15.50%
Current 13.38%
Delta -2.12% R And D Intensity Decreased
Previous 1.55%
Current 1.45%
Delta -0.10% Sbc Intensity Increased
Previous 0.31%
Current 0.51%
Delta 0.20% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.